234 related articles for article (PubMed ID: 7819030)
1. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.
Camplejohn RS; Ash CM; Gillett CE; Raikundalia B; Barnes DM; Gregory WM; Richards MA; Millis RR
Br J Cancer; 1995 Jan; 71(1):140-5. PubMed ID: 7819030
[TBL] [Abstract][Full Text] [Related]
2. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
4. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
5. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
7. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA
Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768
[TBL] [Abstract][Full Text] [Related]
8. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
10. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
11. Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.
Brooks SA; Leathem AJ; Camplejohn RS; Gregory W
Breast Cancer Res Treat; 1993; 25(3):247-56. PubMed ID: 8369526
[TBL] [Abstract][Full Text] [Related]
12. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
13. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
Ottestad L; Pettersen EO; Nesland JM; Hannisdal E; Fosså SD; Tveit KM
Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241
[TBL] [Abstract][Full Text] [Related]
15. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD
Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638
[TBL] [Abstract][Full Text] [Related]
16. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
17. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
[TBL] [Abstract][Full Text] [Related]
18. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
19. Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
J Clin Pathol; 2001 Jul; 54(7):543-9. PubMed ID: 11429427
[TBL] [Abstract][Full Text] [Related]
20. C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
Ann Oncol; 2001 Apr; 12(4):525-33. PubMed ID: 11398888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]